KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

May 22, 2025 at 21:01 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Media Contact

Naomi Goumillout

Agilent Technologies

+1.978.314.1862

naomi.goumillout@agilent.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	279.86	+5.38 (1.96%)
AAPL	306.92	-6.41 (-2.05%)
AMD	478.71	-4.65 (-0.96%)
BAC	63.79	+0.62 (0.98%)
GOOG	352.50	-0.97 (-0.27%)
META	600.25	+8.15 (1.38%)
MSFT	510.13	+10.14 (2.03%)
NVDA	219.32	-4.64 (-2.07%)
ORCL	149.81	+2.79 (1.90%)
TSLA	330.76	+2.18 (0.66%)

Symbol

Price

Change (%)

AMZN

279.86

+5.38 (1.96%)

AAPL

306.92

-6.41 (-2.05%)

AMD

478.71

-4.65 (-0.96%)

BAC

63.79

+0.62 (0.98%)

GOOG

352.50

-0.97 (-0.27%)

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Contacts

More News

Recent Quotes